SAIC-Frederick Taps Silicon Kinetics Technology for Protein Interaction Research | GenomeWeb
NEW YORK (GenomeWeb News) – SAIC-Frederick will use Silicon Kinetics’ technology platform to study protein interactions in cancer and AIDS and to determine how drugs affect those interactions, Silicon Kinetics said today.
 
Under the agreement, National Cancer Institute contractor SAIC-Frederick will use Silicon Kinetics’ three-dimensional, label-free SKi Pro Biomolecular Interaction Analysis Platform in its Protein Chemistry Laboratory to study extracellular binding domains of specific proteins linked to these diseases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.